Morepen Laboratories reports Q3 FY24 consolidated PAT at Rs. 31.99 Cr

Morepen Laboratories reports Q3 FY24 consolidated PAT at Rs. 31.99 Cr

By: IPP Bureau

Last updated : February 02, 2024 11:33 am



Morepen Laboratories has reported total income of Rs. 448.62 crores during the period ended December 31, 2023


Morepen Laboratories Limited has reported consolidated financial results for the period ended December 31, 2023.

Morepen Laboratories has posted net profit of Rs. 31.99 crores for the period ended December 31, 2023 as against net profit of Rs. 21.25 crores for the period ended September 30, 2023. The company posted net profit of Rs.8.99 crores for the period ended December 31, 2022.

Morepen Laboratories has reported total income of Rs. 448.62 crores during the period ended December 31, 2023 as compared to Rs. 425 crores during the period ended September 30, 2023. The company reported total income of Rs.349.68 crores during the period ended December 31, 2022.

For the 9 months period ended December 31, 2023, Morepen Laboratories has reported total income of Rs.1277.08 crores as compared to Rs.1056.85 crores during the 9 months period ended December 31, 2022.

The company has posted net profit of Rs.67.87 crores for the 9 months period ended December 31, 2023 as against net profit of Rs.30.43 crores for the 9 months period ended December 31, 2022.

Morepen Laboratories

First Published : February 02, 2024 12:00 am